ICOS-pathway in T-helper cell
Induction of an immune response requires that T cells receive 2 sets of signals from
antigen-presenting cells. First antigen-specific signal is delivered through T cell
receptor alpha/ beta (TCR alpha/beta) - CD3
complex, while the second co-stimulatory signal is provided by
co-receptors, such as CD28 molecule (CD28) and
Inducible T-cell co-stimulator (ICOS) [1].
ICOS acts as a costimulatory signal for
T-cell proliferation and cytokine secretion, and mediates local tissue responses to
inflammatory conditions, modulates secondary immune response by co-stimulating memory
T-cell function. ICOS stimulation plays an important role in
cell-cell signaling, cytoskeleton, immune responses, and regulation of cell survival.
Iinducible T-cell co-stimulator ligand (ICOS-L) is a ligand
for ICOS [2].
TCR alpha/beta/CD3 complex bound to Major
histocompatibility complex class II (MHC class II) initiates
a biochemical cascade via Lymphocyte-specific protein tyrosine kinase
(Lck) and Zeta-chain (TCR) associated protein kinase 70kDa
(ZAP70). Two known substrates of
ZAP70 are adapter molecules Linker for activation of T cells
(LAT) and Lymphocyte cytosolic protein 2
(Slp76). Phosphorylation of
tyrosine residues on LAT and Slp76
results in recruitment of a number of other proteins involved in
activation of different signaling cascades. The phosphorylated adaptor
LAT binds and activates Phospholipase C, gamma 1
(PCL-gamma 1) [3]. The activated
PCL-gamma 1 is responsible for production of second
messengers diacylglycerol (DAG) and inositol 1, 4,
5-triphosphate (IP3) from cleavage of phospha-tidylinositol
4, 5 bisphosphate (PtdIns(4,5)P2) at plasma membrane.
IP3 and DAG are second
messengers that regulate various processes, such as activation of Nuclear factor of
activated T-cells, cytoplasmic, calcineurin-dependent 2
(NF-AT1(NFATC2)) and Nuclear factor of kappa light
polypeptide gene enhancer in B-cells
(NF-kB),
respectively.
DAG activates Protein kinaseC-theta
(PKC- theta).
PKC- theta activates Inhibitor
of kappa light polypeptide gene enhancer in B-cells, kinase beta (IKK
beta), which phosphorylates Nuclear factor of kappa light polypeptide gene
enhancer in B-cells inhibitor (I-kB) thereby allowing
activation of NF-kB complex.
IP3 induces release of Ca('2+)
from endoplasmatic reticulum. Calcium-bound Calmodulin 2
(Calmodulin) associates with and activates Protein
phosphatase 3 (formerly 2B), catalytic subunits (Calcineurin A
(catalytic)). Calcineurin A (catalytic)
dephosphorylates NF-AT1(NFATC2) family of
transcription factors leading to theirs translocation into the nucleus [4].
CD28 is stimulated by binding of B-cell-specific
cell-surface receptors CD86 molecule
(CD86) and CD80 molecule
(CD80). CD28 enhances T-cell
functions that are essential for effective antigen-specific immune response [5]. In response to activation by the ligands, CD28
can bind to the Phosphatidylinositol 3-kinase, regulatory subunit (PI3K reg
class IA), adaptor proteins Growth factor receptor-bound protein 2
(GRB2), and T cell-specific
IL2-inducible T-cell kinase (ITK).
ITK participates in phosphorylation of LAT
and in the activation of PCL-gamma 1 [6], [7].
Slp76 and GRB2 recruit Vav 1
guanine nucleotide exchange factor (VAV-1), which activates
small GTPases Ras-related C3 botulinum toxin substrate 1
(Rac1) and Cell division cycle 42
(CDC42) involved in regulation of cytoskeleton structure and
remodeling [8].
T-cell receptor itself can't bind and activate phosphatidylinositol kinase. This role
is played by T cell receptor associated transmembrane adaptor 1
(TRIM), which is a novel integral component of
TCR alpha/beta/CD3 complex co-stimulators [9].
Additionally, CD28 and ICOS
recruit and activate Phosphatidylinositol kinase.
TRIM, CD28,
and ICOS bind to PI3K reg class
IA and recruit it to the membrane thereby activating kinase activity.
Active Phosphatidylinositol 3-kinase, catalytical subunit PI3K cat class IA
converts phosphatidylinositol 4,5-biphosphate
(PtdIns(4,5)P2) to phosphatidylinositol 3,4,5-triphosphate
(PtdIns(3,4,5)P3) [10]. Another
phosphatidylinositol kinase isoform, Phosphoinositide-3-kinase, regulatory subunit 5
(PI3K reg class IB (p101)) - Phosphoinositide-3-kinase,
catalytic, gamma polypeptide (PI3K cat class IB
(p110-gamma)), is stimulated by the signal from GPCR via
G-protein beta/gamma. PtdIns(3,4,5)P3
is a second messenger and modulates the activity of v-akt murine thymoma
viral oncogene homolog (AKT(PKB)) and 3-phosphoinositide
dependent protein kinase-1 (PDK(PDPK1)) involved in cell
survival processes [7].
References:
- McAdam AJ, Greenwald RJ, Levin MA, Chernova T, Malenkovich N, Ling V, Freeman GJ, Sharpe AH
ICOS is critical for CD40-mediated antibody class switching.
Nature 2001 Jan 4;409(6816):102-5
- Rudd CE, Schneider H
Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling.
Nature reviews. Immunology 2003 Jul;3(7):544-56
- Lin J, Weiss A
T cell receptor signalling.
Journal of cell science 2001 Jan;114(Pt 2):243-4
- Rusnak F, Mertz P
Calcineurin: form and function.
Physiological reviews 2000 Oct;80(4):1483-521
- Pollard KM, Arnush M, Hultman P, Kono DH
Costimulation requirements of induced murine systemic autoimmune disease.
Journal of immunology (Baltimore, Md. : 1950) 2004 Nov 1;173(9):5880-7
- Marengere LE, Okkenhaug K, Clavreul A, Couez D, Gibson S, Mills GB, Mak TW, Rottapel R
The SH3 domain of Itk/Emt binds to proline-rich sequences in the cytoplasmic domain of the T cell costimulatory receptor CD28.
Journal of immunology (Baltimore, Md. : 1950) 1997 Oct 1;159(7):3220-9
- Rudd CE, Raab M
Independent CD28 signaling via VAV and SLP-76: a model for in trans costimulation.
Immunological reviews 2003 Apr;192:32-41
- Raab M, Pfister S, Rudd CE
CD28 signaling via VAV/SLP-76 adaptors: regulation of cytokine transcription independent of TCR ligation.
Immunity 2001 Dec;15(6):921-33
- Kirchgessner H, Dietrich J, Scherer J, Isomaki P, Korinek V, Hilgert I, Bruyns E, Leo A, Cope AP, Schraven B
The transmembrane adaptor protein TRIM regulates T cell receptor (TCR) expression and TCR-mediated signaling via an association with the TCR zeta chain.
The Journal of experimental medicine 2001 Jun 4;193(11):1269-84
- Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, Waterfield MD
Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer.
Annual review of cell and developmental biology 2001;17:615-75